Download Brochure
Table of Content
Get a Price
March 2025
Principal Consultant
Reviewed By
The global robotic surgery market size is calculated at USD 11.83 billion in 2024, grew to USD 13.79 billion in 2025, and is projected to reach around USD 54.66 billion by 2034. The market is expanding at a CAGR of 16.54% between 2025 and 2034. The increasing number of surgical procedures conducted globally, primarily driven by the rise in chronic diseases and a growing preference for minimally invasive surgeries, boosts market growth.
The market is growing rapidly due to the increasing demand for minimally invasive procedures, which offer quicker recovery and fewer complications. Technological advancements, including enhanced precision and the integration of artificial intelligence, are improving surgical outcomes. The rise in chronic diseases and the need for complex surgeries also contribute to market growth. Robotic surgery offers several benefits for both patients and surgeons, including reduced blood loss, pain, scarring, and infection risk, as well as shorter recovery times.
Widely used in fields like general surgery, gynecology, orthopedics, neurology, urology, and cardiovascular surgery, robotic surgery is advancing with new technologies, offering enhanced capabilities for complex and delicate procedures. Additionally, better healthcare infrastructure and favorable reimbursement policies are making robotic surgeries more accessible, further boosting market expansion.
In July 2024, Bangkok Hospital, one of Thailand's largest private healthcare providers, plans to build a $5 million robotic surgery center featuring da Vinci Xi Surgical Systems. This investment, part of the hospital’s five-year expansion plan, aims to expand robotic surgery across various specialties, including ENT, and focus on education and training to become a Centre of Excellence for robotic surgery in Southeast Asia.
The integration of artificial intelligence in the market is driving significant advancements, enhancing both precision and efficiency in surgical procedures. AI-powered systems are being utilized to improve preoperative planning, facilitate real-time decision-making, and facilitate postoperative analysis. These technologies help automate repetitive tasks, identify patterns, and provide real-time feedback, enabling surgeons to make more informed decisions. AI is also enhancing the precision of robotic arms, reducing human error, and leading to faster recovery times and minimally invasive procedures. With AI's ability to analyze large datasets and predict potential complications, robotic surgeries are becoming increasingly personalized, resulting in improved patient outcomes.
Increasing Prevalence of Chronic Diseases
The rising prevalence of chronic diseases, such as cancer, diabetes, and cardiovascular disorders, is significantly driving the growth of the robotic surgery market. As the demand for more effective and less invasive treatment options grows, robotic surgery has become an essential tool, offering both surgeons and patients enhanced outcomes. This shift toward robotic-assisted procedures is further fueled by the growing demand for complex surgeries and advancements in robotic technology that improve surgical efficiency and precision. For example, a report from the National Library of Medicine in January 2023 projected that the number of people aged 50 and older in the US with at least one chronic condition would nearly double, increasing from 71.5 million to 142.7 million by 2050.
High-cost Robotic Systems and Associated Process
A study by the American Congress of Obstetricians and Gynecologists found that the average cost of a robotic hysterectomy was $8,868, compared to $6,651 for a laparoscopic hysterectomy, making it 1.5 to 3 times more expensive. The initial investment for robotic systems, along with ongoing maintenance, training, and operational costs, can be prohibitive for hospitals and clinics. This creates a barrier to widespread adoption, particularly in settings where budget constraints are a concern.
Technological Advancements in Robotic Surgery
Technological advancements in robotic surgery present a significant opportunity for robotic surgery market growth as they enhance the precision, efficiency, and safety of surgical procedures. Innovations such as improved robotic systems, AI integration, and enhanced imaging capabilities are making surgeries more minimally invasive, reducing recovery times and complications. These advancements not only offer better patient outcomes but also enable hospitals and healthcare providers to expand their service offerings, making robotic surgery more accessible and appealing to a broader patient base. Additionally, the development of more affordable and user-friendly systems creates new market opportunities, particularly in emerging regions.
In January 2024, St. Luke's Medical Center introduced the da Vinci XI, described as the world's most advanced robotic surgical system. According to SLMC, this cutting-edge platform enhances surgeons' precision and control during complex procedures, leading to improved patient outcomes. The system offers 3D high-definition vision, providing surgeons with a clear and detailed view of the surgical site.
By offering, the products segment held the largest share of the robotic surgery market in 2024. A growing need for sophisticated robotic surgical systems and associated technologies. This market has experienced significant growth due to the increasing demand for advanced systems, tools, and software as hospitals and healthcare providers continue to invest in robotic surgery technology to enhance surgical outcomes. The need for these goods was further increased by the spread of robotic surgery into other specialties, including gynecology, urology, and orthopedics. This growth is driven by the widespread use of systems like the da Vinci Surgical System, which has been utilized in over 6 million surgeries worldwide.
By offering these services, the segment is estimated to grow at the fastest rate in the robotic surgery market during the forecast period, driven by increasing demand for comprehensive solutions that extend beyond product offerings. As healthcare providers continue to invest in robotic surgery, the need for training, maintenance, software updates, and technical support services is rising. These services enhance the effectiveness and longevity of robotic systems, driving growth in the services segment. Additionally, as more hospitals adopt robotic surgery, the demand for specialized services to ensure smooth operations and better patient outcomes is expected to increase.
By application, the orthopedics segment dominated the robotic surgery market in 2024 due to the high precision and improved outcomes that robotic systems offer in orthopedic procedures. Robotic technologies, such as the MAKO system for joint replacement, enable surgeons to perform procedures with greater accuracy, resulting in fewer complications, reduced recovery time, and improved long-term outcomes. Orthopedic surgeons typically address issues like fractures, arthritis, ligament and tendon injuries, congenital conditions, spinal abnormalities, and sports-related injuries. Additionally, the growing incidence of bone and joint disorders, particularly among the aging population, has significantly boosted the demand for robotic-assisted orthopedic surgeries, making this segment the largest in the market.
By applications, the general surgery segment is projected to grow at the fastest CAGR in the robotic surgery market during the predicted timeframe—increased adoption of robotic-assisted systems for a wide range of procedures. Robotic surgery offers several advantages, including greater precision, minimally invasive techniques, and faster recovery times, which are particularly beneficial in general surgeries like gallbladder removal, hernia repairs, and abdominal surgeries. Over 30% of general surgeries in the U.S. are expected to be performed using robotic assistance by 2027. Moreover, the rising demand for better patient outcomes, reduced complications, and quicker recovery is driving the use of robotic systems in general surgery, contributing to its rapid growth.
By end-user, the hospitals segment dominated the global robotic surgery market in 2024, driven by extensive infrastructure, advanced surgical equipment, and highly skilled medical teams. Hospitals are the primary venues for performing complex robotic surgeries across various specialties, including orthopedics, urology, and general surgery. The increasing adoption of robotic systems in hospitals, driven by the need for greater precision, shorter recovery times, and enhanced patient outcomes, has solidified their market dominance. The growing incidence of chronic illnesses and traumatic injuries, along with the availability of reimbursement policies for surgical procedures, is driving the demand for advanced surgical interventions. Additionally, hospitals offer a comprehensive range of services, making them the top choice for robotic surgery procedures.
By end-user, the ambulatory surgical centers segment is expected to witness the fastest growth in the robotic surgery market over the coming years. Ambulatory surgical centers (ASCs) offer a cost-effective and efficient alternative to hospitals for various surgical procedures, especially minimally invasive ones, which are ideal for robotic surgery. These centers focus on same-day discharge, reducing hospital stays and associated costs, which makes robotic surgeries more accessible to a broader patient base. Additionally, ASCs are increasingly adopting advanced robotic systems to enhance surgical precision, minimize complications, and reduce recovery times, further fueling their market growth.
North America led the robotic surgery market in 2024. The region benefits from advanced healthcare infrastructure, high adoption rates of cutting-edge medical technologies, and significant investment in robotic systems by hospitals and healthcare providers. Additionally, the presence of leading robotic surgery companies, such as Intuitive Surgical and Medtronic, coupled with strong reimbursement policies and a growing demand for minimally invasive surgeries, has driven the market's growth. Moreover, the rising prevalence of chronic diseases and the adoption of robotic-assisted surgeries for various specialties further solidified North America's dominance in the market. In 2024, Intuitive Surgical announced plans to invest $400 million in expanding its manufacturing and training facilities in the region, thereby strengthening its position and ensuring continued leadership in the market.
The demand for faster recovery times drives the increasing use of minimally invasive procedures in the country. Favorable reimbursement policies, the growing demand for minimally invasive procedures, and the rising prevalence of chronic diseases have further fueled market growth. Additionally, the presence of top medical centers and skilled surgeons has solidified the U.S. dominance in the market.
In September 2023, US Medical Innovations (USMI) and the Jerome Canady Research Institute (JCRI-ABTS) introduced the Canady Robotic AI Surgical System, the world’s first AI-driven robotic system that combines cold atmospheric plasma (CAP) and a 3D non-contact bioelectric pulsed electromagnetic field. Innovations like these are expected to drive further growth in the market.
The Canadian market is experiencing growth due to increased demand for precision surgeries and faster recovery times. For instance, in 2023, Toronto General Hospital introduced the da Vinci Surgical System for urological and gastrointestinal procedures 2023. Additionally, the Ontario government allocated $10 million to expand robotic surgery across hospitals, fueling further growth. With a rising aging population and higher rates of chronic diseases, Canada is seeing the continued adoption of advanced surgical technologies.
Asia Pacific is estimated to grow at the fastest rate in the market during the forecast period. Increasing healthcare investments, rapid advancements in medical technology, and a growing demand for minimally invasive procedures are driving the market. Additionally, rising healthcare expenditures, an aging population, and the prevalence of chronic diseases like cancer and cardiovascular conditions in countries such as China, India, and Japan are fueling adoption. The government's support and investments in healthcare innovation also play a crucial role in driving market expansion in the Asia-Pacific region.
In May 2023, AIIMS New Delhi partnered with Medtronic India to launch an advanced surgical robotics training center at AIIMS. The center will offer comprehensive training programs, encompassing a range of skills from basic robotic surgery techniques to specialized methods in soft-tissue surgery, designed to enhance expertise in robotic-assisted surgery (RAS).
The Chinese market is growing due to increased healthcare investments, an aging population, and the rising prevalence of chronic diseases. In 2023, Peking University First Hospital became one of the first institutions in China to adopt the da Vinci Xi robotic system for complex surgeries, marking a significant step forward in the country's push toward advanced surgical technologies. Additionally, government support and the growing medical tourism industry are further driving the market's expansion.
The Indian market is experiencing growth due to rising demand for minimally invasive procedures, advancements in medical technology, and an increasing focus on enhancing surgical outcomes. The country's large population and rising prevalence of chronic diseases, such as cancer and heart conditions, are driving the adoption of robotic-assisted surgeries. Additionally, government initiatives, increasing healthcare investments, and expanding medical tourism are further fueling market growth.
India's SSI Mantra robotic system achieved a major milestone by performing two robotic cardiac surgeries via telesurgery over a distance of 286 kilometers. Conducted by Dr. Sudhir Srivastava remotely, the surgeries included a Telerobotic-assisted artery harvesting and a beating heart bypass, with latency as low as 35-40 milliseconds. This marks a significant advancement in remote surgery, enabling high-quality care across geographical boundaries, particularly benefiting rural areas.
Europe is expected to experience significant growth in the robotic surgery market, driven by well-established healthcare infrastructure and favorable reimbursement policies that lower patients' out-of-pocket costs. Furthermore, ongoing research in the region is expected to drive market growth further. For example, EU-funded research is advancing the development of innovative microrobots, which are designed to be less invasive, more affordable, and capable of reducing complications in complex surgeries.
Several key factors drive the growth of the UK market. The country’s robust healthcare system, primarily funded by the government through the National Health Service (NHS), ensures widespread access to healthcare, including advanced medical technologies such as robotic surgery. With the NHS under pressure to improve efficiency while maintaining universal access, there is a growing focus on adopting technologies that offer improved patient outcomes, reduced recovery times, and enhanced precision. Additionally, the increasing demand for robotic surgery, driven by its benefits such as reduced blood loss and faster recovery, is contributing to market growth.
The German market is experiencing growth due to the country's robust healthcare infrastructure, high demand for advanced surgical technologies, and increasing preference for minimally invasive procedures. Germany has been at the forefront of adopting robotic surgical systems, with hospitals increasingly investing in robotic-assisted surgeries to achieve improved precision, faster recovery times, and reduced complications. Additionally, Germany’s research and development efforts in medical robotics, along with favorable reimbursement policies, are further boosting market expansion.
In September 2024, Park Hospital in Gurugram introduced a Robotic-Assisted Surgery program utilizing the da Vinci system to enhance surgical precision and reduce recovery times. The program encompasses specialties such as general surgery, oncology, gynecology, and urology. Dr. Anshuman Kaushal commented, "Robotic surgery enhances precision and reduces recovery time," while Dr. Salil Yadav added, "It offers minimally invasive procedures with better outcomes." This initiative aims to provide advanced care with quicker recoveries.
By Offering
By Applications
By End-User
By Region
March 2025
March 2025
March 2025
March 2025
Schedule a Meeting